Cohesins appear to have critical functions beyond mitotic cohesion. Our data on a cohesin-associated Pds5-paralog, APRIN, indicate a novel cohesin role in stem cell differentiation. APRIN/Pds5B is lost in many cancers and it is a putative tumor suppressor. Its mutations in the germ line, however, generate birth defects. We reasoned that as both cancer and birth defects share disrupted stem cell differentiation, the data suggest an APRIN/Pds5B cohesin function in stem cells. We used an embryonal carcinoma stem cell model and show here that (i) APRIN expression is precisely coordinated with stem cell differentiation; (ii) this coordination involves surface-contact and endocrine pathways; and (iii) APRIN/Pds5b coordination is critical in stem/progenitor exit decisions. APRIN knockdown disrupted Oct4, Nanog and SOX2 patterns, differentiation failed and the resulting immature proliferative cells did not progress beyond proneural progenitor phase. Furthermore, the phenotype-blocked progenitor exit (Mash-1 þ ); failed E-cadherin exit (E-Cadh low þ ); incomplete N-cadherin transition (N-Cadh low þ ); retained proliferative capacity (c-myc þ ); irregular stemness (SOX2 late þ þ ) and lost response to contact and hormonal cues-shares similarities with cancer-initiating cells. The data suggest novel APRIN/Pds5B-linked cohesin roles in stem/progenitor programs and a new mechanism in tumor suppression.
Expression of stem cell markers in cancers with various levels of histological dedifferentiation strongly suggests that cancer is ultimately a disease of differentiation. Pathway analyses indicate that the anomaly takes place early in the stem/progenitor program in most cancers (Ailles and Weissman, 2007) . The disrupted stem cells represent a new entity called 'cancer stem cells' or 'cancer-initiating cells' that shows disrupted exit from pluri-or multipotency. The factors that regulate exit mechanisms, however, are not known. The data we present suggest that exit regulation may be a novel, unexpected function of cohesins and losing a cohesinassociated factor disables exit programs and recapitulates cancer stem cell phenotypes.
We previously searched for early differentiation regulators and established a gene pool in a hormonal cancer model (Geck et al., 1997) . We showed that one of the new genes, APRIN/Pds5B (formerly AS3), was involved in proliferative arrest in vitro (Geck et al., 2000) and in vivo (Maffini et al., 2002) . APRIN is a candidate tumor suppressor, its role in cancer pathways, its genomic losses or downregulation were detected in a variety of cancers and cancer cell lines (Geck et al., 2001) , including esophageal (Harada et al., 2001; Zhang et al., 2008) , head and neck (Reis et al., 2005) , cervical (Seo et al., 2005) , prostate (Murthy et al., 2005) and others.
APRIN/Pds5B mutations in the germ line, on the other hand, were shown to contribute to Cornelia de Lange-type birth defects in mice and in humans (Zhang et al., 2009) . APRIN, therefore, has a unique double role: its defects in the germ line induce systemic malformations, whereas its disruptions in somatic cells result in cancer. As the underlying mechanisms in both birth defects and cancer appear to be stem cell related, we investigated the hypothesis of APRIN involvement in stem cell regulation.
To analyze the putative stem cell functions of APRIN/Pds5B, we used the P19 embryonal carcinoma stem cell model with well-characterized stem cell and differentiation properties (Jones-Villeneuve et al., 1982 , 1983 McBurney and Rogers, 1982; Bain et al., 1994) . These pluripotent immortalized stem cells are the functional equivalents of epiblast cells in the early post-implantation blastocyst (Xia et al., 2007) . They can generate derivatives of all three primary germ layers and a variety of differentiation pathways appear to be intact (Smith et al., 1987; Gao et al., 2001) . Retinoic acid treatment in 3-dimensional aggregate cultures (spheroids) orchestrates terminal differentiation into neuronal and glial phenotypes in a well-established time course (Jones-Villeneuve et al., 1982) .
To investigate correlations between APRIN/Pds5B and differentiation, we first analyzed APRIN expression at critical points in this differentiation time course (days 0, 1, 2, 4 and 9) (Mani et al., 2001) . We found rapid early induction on day 1 (2.8-fold) (Figure 1a ), further increase from day 2 to day 4 (4.5-fold,) and long-term constitutive mid-level expression in post-spheroid terminal differentiation (2.9-fold by day 9). The significant induction suggested that APRIN was involved in the differentiation process and prompted further studies.
To investigate the induction mechanisms in more detail, we dissected the induction pathways. By omitting retinoic acid from the protocol, the 3-dimensional aggregate-induced surface contacts were sufficient to trigger high APRIN levels by day 1 (Figure 1b , lanes 4 vs 2). Without retinoic acid, however, the effect dissipated by day 4 (lanes 5 vs 3). In turn, retinoic acid treatment alone failed to induce APRIN on day 1 (Figure 1b , lanes 6 vs 2), but it reached high levels by day 4 (lanes 7 vs 3). APRIN expression beyond day 4 required no hormonal or contact effects ( Figure 1a , lane 5). In conclusion, induction was contact-dependent in the early phase ( Figure 1c , 'day 1'), hormonedependent in the late phase ('Day 4'), and constitutive in post-mitotic, terminal differentiation ('Diff.'). As in post-mitotic cells no mitosis or cohesion occur, constitutive expression of a cohesin factor was surprising and indicated a function unrelated to mitotic cohesion.
The observed unique contact-dependency of early APRIN/Pds5B induction prompted further studies on surface mediators. The predominant cell-adhesion molecule both in the early embryo and in P19 cells is E-Cadherin (Mummery et al., 1991; Teramoto et al., 2005) and it is known to be involved in early development (Halbleib and Nelson, 2006) . It is also known, however, that E-Cadherin is rapidly replaced by N-Cadherin in neuronal differentiation (Gao et al., 2001) . To determine which pathway was active in the contact-phase, our studies showed that E-Cadherin was still predominant on day 1 (Figure 2a) . Furthermore, inhibitory E-Cadherin antibodies that block E-Cadherin signaling (Vestweber and Kemler, 1985) prevented spheroid formation (Figure 2b ) and blocked APRIN induction (Figure 2c ). The presence of blocking antibodies was verified by Alexa 488-labeled secondary antibody staining (Supplementary Figure 1) . The results suggest that the early-contact pathway of APRIN induction is largely E-Cadherin-dependent.
The finding that APRIN/Pds5B was under complex regulation by three different pathways (contact, hormonal and constitutive) suggested an important function. To assess this function and to study the effect of APRIN silencing in cancer cell biology, we knocked down APRIN by RNA interference. We show that small interfering RNA transfection was highly efficient (70-90% as tested by TAM-labeled small interfering RNA) and it lasted beyond 4 days (Supplementary Figure 2) . As a result, the small interfering RNA-mediated knock- APRIN/Pds5B silencing significantly changed the P19 differentiation phenotype and cell morphology. The cells remained rounded/polygonal with occasional abortive neurites (Figure 3c , 'siAPRIN'; compare with extensive neurite outgrowth in 'siScrambled'). The morphology suggested that neurogenic differentiation was disrupted and the differentiation program appeared to be arrested in the majority of P19 cells.
To identify the point of arrest, we performed quantitative time course analyses with key stem/progenitor regulators. Oct4 (Pou5f1) is the recently recognized master gene of embryonal stem cell maintenance: it can induce pluripotent stem cells, either in combinations with Sox2, c-myc and Klf4 (Takahashi and Yamanaka, 2006; Kim et al., 2008) , or alone (Kim et al., 2009) . Nanog is also known to cooperate with Oct4 (Suzuki et al., 2006) . Therefore, we decided to test Oct4, Sox2, c-myc and Nanog as markers of the early phase (Klf4 is critical only in the induced pluripotent stem cell procedure by repressing p53) (Rowland et al., 2005) . These and the other marker genes we selected (see later) are extensively characterized in P19 differentiation (Itoh et al., 1997; Wei et al., 2002) .
Our results showed that Oct4 was highly expressed in undifferentiated P19 cells and rapidly downregulated in normal differentiation (8% within 24 h), consistent with published data (Okita and Yamanaka, 2006) (Figure 4 , panel OCT4). In APRIN-knockdown cells, however, the program failed within the first 24 h and Oct4 remained high (B70% of the uninduced levels). Downregulation was delayed and took place only between day 2 and 2.5.
Nanog and Sox2 were also disrupted. Both were expressed at high levels in uninduced P19 cells (Figure 4 , NANOG and SOX2) and induction further increased Nanog by day 1. In normal neurogenic differentiation, Nanog decreased completely after day 2, whereas Sox2 fell by 50% and kept this level along the progenitor phase. In APRIN knockdown, however, both the early Nanog increase and the high Sox2 levels were abrogated. Paradoxically, although Sox2 fell in the early phase, we found unscheduled, irregularly high overexpression (2.5-fold) after day 2 that subsided only by day 7.
Expression of c-Myc was high in uninduced, proliferative P19. After induction, the cells became synchronized within 24 h through proliferative arrest and c-Myc repression (Figure 4 , c-MYC), consistent with published data (Wei et al., 2002) . During days 2 and 3, the cells entered a 'transit-amplifying' phase with a sharp increase in c-Myc levels. By days 4 and 5, the cells reached differentiation, proliferation was arrested with APRIN role in stem cell differentiation and cancer V Denes et al c-Myc decline, although in some experiments c-Myc slowly increased later due to a minor non-committed population. In APRIN knockdown, the pattern was abrogated, c-Myc failed to downregulate and proliferation continued.
We also investigated further markers to monitor stem cell exit and progenitor transition. N-Cadherin, a neurogenic differentiation marker was not expressed in control, proliferating P19 cells and it reached high levels by day 4 after normal induction (Figure 4, N-Cadherin) , as shown before (Gao et al., 2001) . In APRIN-knockdown cells, N-Cadherin induction was delayed, incomplete and ultimately failed to reach normal levels (B50% of normal). In contrast, E-Cadherin was normally high in the early-contact phase, partially downregulated by day 2 and completely by day 4 (Figure 4 , E-Cadherin) (Gao et al., 2001; Halbleib and Nelson, 2006) . In APRIN-knockdown cells, although E-Cadherin fell rapidly, it failed to downregulate beyond day 2 levels and showed an unscheduled increase (B4-fold) in the post-spheroid phase.
To monitor progenitor progression and exit, we tested Mash-1, a proneural master gene and marker of progenitor progression (Gohlke et al., 2008) . Mash-1 was not expressed in normal undifferentiated P19 stem cells, highly expressed by day 4 and normally disappeared by terminal differentiation (Figure 4, MASH-1) . In APRINknockdown cells, Mash-1 induction failed in the most critical first 4 days. Paradoxically, after this point Mash-1 showed unusual, continuous overexpression (ninefold).
By comparing the changes with the APRIN/Pds5 pattern, we could outline tentative functional correlations (Figure 4, APRIN) . Disruption of Oct4, Nanog and c-Myc coincided with the missing early phase of APRIN, suggesting that the contact APRIN phase is critical for stem cell exit and arrest synchronization. On the other hand, the failure to downregulate Sox2, cMyc, E-Cadherin and Mash-1, together with the incomplete N-Cadherin pattern, coincided with the missing late APRIN phase. This, in turn, suggested that the hormonal APRIN phase is required for progenitor exit and terminal differentiation. Interestingly, most of the genes we tested failed to downregulate without APRIN, suggesting that the APRIN/Pds5B cohesin complex may function as a repressor.
Altogether, our studies on the P19 differentiation model revealed complex APRIN/Pds5B regulation and a critical role in stem cell differentiation. We showed that APRIN silencing disrupted top regulators in stem cell biology and resulted in aberrant Oct4, Nanog and Sox2 patterns. Oct4 delay was particularly significant, as even minor changes in Oct4 levels were shown to have major effects on differentiation (Niwa et al., 2000) . The marker signature we present here also indicates disruptions at multiple levels. Failed E-cadherin downregulation (E-Cadh low þ ) and delayed irregular neural stemness (SOX2 late þ þ ) signaled irregular stem cell exit. Incomplete N-cadherin induction (N-Cadh low þ ) was a sign of the disrupted progenitor program, in which constitutive expression of the proneural master gene (Mash-1 þ ) localized the point of arrest at the proneural level.
Continuous proliferation (c-myc þ ) indicated missing early synchronization and confirmed that progenitor exit also failed.
In sum, the cell morphology and the marker data suggested that stem cell differentiation was arrested at a transient, proliferative phase in the proneural stage of the progenitor program. Furthermore, we noticed that the resulting pattern (arrested stem cell differentiation, persistent embryonic stem/progenitor markers, lost contact signaling, hormone resistance, continued proliferation and so on) shared characteristics with cancer stem cells (Ailles and Weissman, 2007) . Although speculative, our data suggest a new potential tumor suppressor mechanism, in which cohesins (in APRIN/ Pds5b complex) can prevent the emergence of cancer stem cells by facilitating stem cell progression and terminal differentiation.
The findings raised interesting questions about the molecular mechanisms of APRIN/Pds5B. APRIN evolved by gene duplication from the ancient Pds5 lineage, which shows high conservation from yeast to human (Geck et al., 1999; Maffini et al., 2008) . Pds5A, the vertebrate ortholog of this lineage (SCC112 in human) (Kumar et al., 2004; Zheng et al., 2008) , is a cohesin-associated protein with long evolution from unicellular eukaryotes (Berney and Pawlowski, 2006) . APRIN also contributes to sister chromatid cohesion in mitosis (Losada et al., 2005) , and its loss is expected to result in precociously dissociated sister chromatids (hence its name in the cohesin field, 'precocious dissociation of sister-chromatids protein 5B', or Pds5B). However, the model does not explain the high APRIN levels in postmitotic tissues in which no replication or cohesion occurs (muscle, brain) (Geck et al., 1999) , and the complete lack of precociously dissociated sister chromatids in animals in which the 'precocious dissociation of sister-chromatids protein 5B' was knocked out . APRIN evolution also suggests diversified functionalities. Release 12 of the Pfam-A database (2004) identified that APRIN is a chimeric gene with two successive acquisitions of unique HMG DNA-binding domains (AT-hooks), not present in Pds5A or any of the cohesin factors. Furthermore, APRIN diversified extensively, by 27% from its human Pds5A paralog (Maffini et al., 2008) .
These data, together with the novel stem cell functions we present here, strongly suggest a role for the APRIN/Pds5B cohesin complex in gene expression. Some of the APRIN domains (HEAT, HMG) are hallmarks of chromatin architectural regulators (Aravind and Landsman, 1998; Cattaruzzi et al., 2007) . Cohesins have recently been shown to share functions with chromatin insulators in CTCF complex (Parelho et al., 2008; Wendt et al., 2008) . The data suggest that the APRIN/Pds5B cohesin complex may have the capacity to reconfigure the chromatin architecture in interphase. The local chromatin rearrangements, in turn, may act to downregulate stagespecific genes at phase transitions to facilitate differentiation. The biological consequences of APRIN loss depend on the host cell. If it happens in the germ line the result is birth defects, whereas in somatic cells APRIN silencing shows significant correlation with cancer.
Our data support the hypothesis that the link between APRIN-related birth defects and cancer is disrupted early stem cell differentiation. Our data also suggest that without a novel, intriguing stem cell function of cohesins stem cell exit appears to fail. Speculatively, if our hypothesis is correct, patients with Cornelia de Lange syndrome should develop cancer with higher frequency. In fact, unusual, aberrant tumors are frequently reported in Cornelia de Lange patients, if they reach a certain age Sugita et al., 1986; Maruiwa et al., 1988; DuVall and Walden, 1996; Liu and Krantz, 2009) .
Cancer stem cells appear to be at the core of cancer pathophysiology, but the mechanisms and the origin of deviant, cancer-initiating cells is not understood. Our results suggest that part of the mechanisms may relate to an unexpected function of cohesins.
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